Clinical Trials in Dallas

Showing 4141-4160 of 17,468 trials

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

NCT02602262

HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be followed.

HIV Infection

Johns Hopkins University105 participantsStarted Nov 2015

Aurora, Colorado, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +15 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS).

Carcinoma, Renal Cell

Merck Sharp & Dohme LLC1,800 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • La Jolla, California, United States +282 more locations

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Find Trials by Condition in Dallas

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Topical ENS-002 for Atopic Dermatitis in Adults

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Expanded Access of Sotorasib

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours